Xolair Monitoring

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org

2 posts / 0 new
Last post
Emily K D'Anna
Emily K D'Anna's picture
Offline
Last seen: 2 days 11 hours ago
Joined: 02/07/2017 - 11:38
Xolair Monitoring

Hi there!

I wondered if anyone had any protocols or guidelines in your ambulatory spaces regarding monitoring / observation recommendations following administration of Omalizumab (Xolair®) in the outpatient or infusion center setting?

Thanks so much in advance,
Sincerely,

Emily

Attach files :

Tags: